These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

788 related articles for article (PubMed ID: 9811723)

  • 41. Lentivirus vector gene expression during ES cell-derived hematopoietic development in vitro.
    Hamaguchi I; Woods NB; Panagopoulos I; Andersson E; Mikkola H; Fahlman C; Zufferey R; Carlsson L; Trono D; Karlsson S
    J Virol; 2000 Nov; 74(22):10778-84. PubMed ID: 11044122
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The tumor suppressor protein p53 strongly alters human immunodeficiency virus type 1 replication.
    Duan L; Ozaki I; Oakes JW; Taylor JP; Khalili K; Pomerantz RJ
    J Virol; 1994 Jul; 68(7):4302-13. PubMed ID: 8207805
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of small hairpin RNA by lentivirus-based vector confers efficient and stable gene-suppression of HIV-1 on human cells including primary non-dividing cells.
    Nishitsuji H; Ikeda T; Miyoshi H; Ohashi T; Kannagi M; Masuda T
    Microbes Infect; 2004 Jan; 6(1):76-85. PubMed ID: 14738896
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HIV-1-based lentiviral vectors.
    Liu YP; Berkhout B
    Methods Mol Biol; 2014; 1087():273-84. PubMed ID: 24158830
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A HIV-2-based self-inactivating vector for enhanced gene transduction.
    Mukherjee S; Lee HL; Pacchia AL; Ron Y; Dougherty JP
    J Biotechnol; 2007 Jan; 127(4):745-57. PubMed ID: 16979253
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chimeric HIV-1 and HIV-2 lentiviral vectors with added safety insurance.
    Sachdeva G; D'Costa J; Cho JE; Kachapati K; Choudhry V; Arya SK
    J Med Virol; 2007 Feb; 79(2):118-26. PubMed ID: 17177309
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel bovine lentiviral vectors based on Jembrana disease virus.
    Metharom P; Takyar S; Xia HH; Ellem KA; Macmillan J; Shepherd RW; Wilcox GE; Wei MQ
    J Gene Med; 2000; 2(3):176-85. PubMed ID: 10894263
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of HIV-1 by a Lentiviral Vector with a Novel Tat-Inducible Expression System and a Specific Tropism to the Target Cells.
    Farazmandfar T; Haghshenas MR; Shahbazi M
    Hum Gene Ther; 2015 Oct; 26(10):680-7. PubMed ID: 26077977
    [TBL] [Abstract][Full Text] [Related]  

  • 49. StpC-based gene therapy targeting latent reservoirs of HIV-1.
    Turner LS; Tsygankov AY; Henderson EE
    Antiviral Res; 2006 Dec; 72(3):233-41. PubMed ID: 16891001
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G.
    Jeeninga RE; Hoogenkamp M; Armand-Ugon M; de Baar M; Verhoef K; Berkhout B
    J Virol; 2000 Apr; 74(8):3740-51. PubMed ID: 10729149
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhanced inhibition of human immunodeficiency virus type 1 replication by novel lentiviral vectors expressing human immunodeficiency virus type 1 envelope antisense RNA.
    Mautino MR; Morgan RA
    Hum Gene Ther; 2002 Jun; 13(9):1027-37. PubMed ID: 12067436
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A sensitive promoter assay based on the transcriptional activator Tat of the HIV-1 virus.
    Koken SE; van Wamel J; Berkhout B
    Gene; 1994 Jul; 144(2):243-7. PubMed ID: 8039709
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of a novel trans-lentiviral vector that affords predictable safety.
    Wu X; Wakefield JK; Liu H; Xiao H; Kralovics R; Prchal JT; Kappes JC
    Mol Ther; 2000 Jul; 2(1):47-55. PubMed ID: 10899827
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Coordinate enhancement of transgene transcription and translation in a lentiviral vector.
    Yilmaz A; Fernandez S; Lairmore MD; Boris-Lawrie K
    Retrovirology; 2006 Feb; 3():13. PubMed ID: 16480517
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of minimal lentivirus vectors derived from simian immunodeficiency virus (SIVmac251) and their use for gene transfer into human dendritic cells.
    Mangeot PE; Nègre D; Dubois B; Winter AJ; Leissner P; Mehtali M; Kaiserlian D; Cosset FL; Darlix JL
    J Virol; 2000 Sep; 74(18):8307-15. PubMed ID: 10954529
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhanced transgene expression in cord blood CD34(+)-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors.
    Sirven A; Ravet E; Charneau P; Zennou V; Coulombel L; Guétard D; Pflumio F; Dubart-Kupperschmitt A
    Mol Ther; 2001 Apr; 3(4):438-48. PubMed ID: 11319904
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Helper plasmids for production of HIV-1-derived vectors.
    Fuller M; Anson DS
    Hum Gene Ther; 2001 Nov; 12(17):2081-93. PubMed ID: 11747598
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of the central polypurine tract on the kinetics of human immunodeficiency virus type 1 vector transduction.
    Van Maele B; De Rijck J; De Clercq E; Debyser Z
    J Virol; 2003 Apr; 77(8):4685-94. PubMed ID: 12663775
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Second-site long terminal repeat (LTR) revertants of replication-defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription factors TFIID and TFIIA.
    Kashanchi F; Shibata R; Ross EK; Brady JN; Martin MA
    J Virol; 1994 May; 68(5):3298-307. PubMed ID: 8151790
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lentivirus-mediated gene transfer and expression in established human tumor antigen-specific cytotoxic T cells and primary unstimulated T cells.
    Zhou X; Cui Y; Huang X; Yu Z; Thomas AM; Ye Z; Pardoll DM; Jaffee EM; Cheng L
    Hum Gene Ther; 2003 Jul; 14(11):1089-105. PubMed ID: 12885348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.